MALVERN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- YPrime, a proven leader in clinical trial technology, today announced the launch of its Advanced eCOA Oversight functionality—a key enhancement to its ...
New functionality aligns with EMA, FDA, and ICH E6(R3) expectations for documented investigator review, endorsement, and sign-off of participant data MALVERN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ...
New functionality aligns with EMA, FDA, and ICH E6, a proven leader in clinical trial technology, today announced the launch of its Advanced eCOA Oversightfunctionality-a key enhancement to its eCOA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results